biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a1ls-01a-12d-a159-09
biospecimen_aliquot__bcr_aliquot_uuid	40087f80-85f6-4cc4-95c9-0639153dd3f4
biospecimen_aliquot__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a1ls-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099054567
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-05-17
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a159
biospecimen_aliquot__plate_row	h
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.92
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a1ls-01a-12d
biospecimen_analyte__bcr_analyte_uuid	7de33e71-93bc-43ab-af7a-3a7dd4ad8bf6
biospecimen_analyte__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a1ls-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	2
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a1ls
biospecimen_diagnostic_slides__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a1ls-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	9a43a58a-df40-4375-8456-ef0071bc9eb9
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a1ls
biospecimen_normal_control__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
biospecimen_normal_control__normal_tissue_anatomic_site	breast
biospecimen_portion__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
biospecimen_portion__bcr_portion_barcode	tcga-e2-a1ls-01a-12
biospecimen_portion__bcr_portion_uuid	01427736-4cac-4dd6-956f-79040d11bec0
biospecimen_portion__bcr_sample_barcode	tcga-e2-a1ls-01a
biospecimen_portion__date_of_creation	2011-03-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	12
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	10.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a1ls-01a-12d
biospecimen_protocol__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a1ls-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
biospecimen_sample__bcr_sample_barcode	tcga-e2-a1ls-01a
biospecimen_sample__bcr_sample_uuid	529056f9-7bdf-4675-bff7-a82abddf5734
biospecimen_sample__days_to_collection	176
biospecimen_sample__initial_weight	100
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e2-a1ls.a514658a-fb29-4aa0-9451-2a960b3720c1.pdf
biospecimen_sample__pathology_report_uuid	a514658a-fb29-4aa0-9451-2a960b3720c1
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a1ls-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	9e7e3f34-faa6-4a3d-a0cb-d733c45b9b65
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17j
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a1ls-01a-21-a17j-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
biospecimen_slide__bcr_sample_barcode	tcga-e2-a1ls-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a1ls-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	ab745fbc-dd5a-47f7-b60e-9533e52465e6
biospecimen_slide__image_file_name	tcga-e2-a1ls-01a-01-tsa.ab745fbc-dd5a-47f7-b60e-9533e52465e6.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	2
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	1
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	20
biospecimen_slide__percent_tumor_cells	80
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a1ls
biospecimen_tumor_sample__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
clinical_drug__bcr_drug_barcode	tcga-e2-a1ls-d20604
clinical_drug__bcr_drug_uuid	225992d9-0568-4dd6-bf26-d1c6e065c3de
clinical_drug__bcr_patient_barcode	tcga-e2-a1ls
clinical_drug__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
clinical_drug__form_completion_date	2012-1-17
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	cyclophosphamide
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	112
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__regimen_number	1
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-e2-a1ls-f70016
clinical_follow_up__bcr_followup_uuid	d73a246d-93ce-4e3c-8364-a243efa91c86
clinical_follow_up__bcr_patient_barcode	tcga-e2-a1ls
clinical_follow_up__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2015-2-9
clinical_follow_up__last_contact_days_to	1604
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	46
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage ia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	right lower outer quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-e2-a1ls
clinical_patient__bcr_patient_uuid	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533
clinical_patient__birth_days_to	-16887
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score 0+0 = 0
clinical_patient__er_positivity_scale_other	allred score = 0
clinical_patient__er_status_by_ihc	negative
clinical_patient__form_completion_date	2011-6-3
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	239
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	5
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a1ls
clinical_patient__pr_positivity_define_method	allred score 0+0 = 0
clinical_patient__pr_positivity_scale_other	allred score = 0
clinical_patient__pr_status_by_ihc	negative
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1LS-01A-12D-A159-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1LS-01A-12D-A159-09.bed.meta
manually_curated__id	tcga-e2-a1ls-01a-12d-a159-09
manually_curated__md5sum	79a27689588de9420221a6fce8250085
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	40087f80-85f6-4cc4-95c9-0639153dd3f4
manually_curated__tumor_tag	brca
